New Daily Persistent Headache in Children and Adolescents
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
New daily persistent headache (NDPH) is a form of chronic daily headache (CDH) that may have features of both migraine and tension-type headache. In contrast with other types of CDH, NDPH is characterized by patients recalling the specific date their unremitting daily headache began. In comparison, chronic tension-type headache and chronic migraine are preceded by a gradually increasing frequency of headache. After several months, all three of these CDH forms often have a similar phenotype, making early history a key to diagnosing NDPH. Evaluations to exclude secondary causes are necessary but usually negative. NDPH is difficult to treat and requires a multimodal approach. Questions regarding NDPH remain unanswered. Additional prospective studies are necessary to further understand, characterize, diagnose, and treat NDPH.
- Vanast WJ: New daily persistent headaches: definition of a benign syndrome. Headache 1986, 26:317–320.
- Siberstein SD, Lipton RB, Solomon S, et al.: Classification of daily and near-daily headaches: proposed revisions to the IHS criteria. Headache 1994, 34:1–7.
- Headache Classification Subcommittee of the International Headache Society: The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004, 24(Suppl 1):9–160.
- • Kung E, Tepper SJ, Rapoport AM, et al.: New daily persistent headache in the paediatric population. Cephalalgia 2009, 29:17–22. This article presents the most recent NDPH epidemiology data in a pediatric headache clinic population. It also proposes that NDPH be classified by abrupt onset of daily headache, given that its phenotype is similar to that of other forms of CDH.
- Li D, Rozen TD: The clinical characteristics of new daily persistent headache. Cephalalgia 2002, 22:66–69. CrossRef
- Mack KJ: New daily persistent headache in children and adults. Curr Pain Headache Rep 2009, 13:47–51. CrossRef
- Abdelsalam HHM, Guo Y, Rothner AD: New daily persistent headache in children and adolescents [abstract]. Ann Neurol 2004, 56:S83–S131. CrossRef
- Scher AI, Stewart WF, Liberman J, et al.: Prevalence of frequent headache in a population sample. Headache 1998, 38:497–506. CrossRef
- Castillo J, Munoz P, Guitera V, et al.: Kaplan Award 1998. Epidemiology of chronic daily headache in the general population. Headache 1999, 39:190–196. CrossRef
- Winner P, Lewis DW, Rothner AD: Headache in Children and Adolescents, edn 2. New York: BC Decker Inc.; 2008.
- Wang SJ, Fuh JL, Lu SR, et al.: Chronic daily headache in adolescents: prevalence, impact, and medication overuse. Neurology 2006, 66:193–197. CrossRef
- Grande RB, Aaseth K, Lundqvist C, et al.: Prevalence of new daily persistent headache in the general population. The Akershus study of chronic headache. Cephalalgia 2009, 29:1149–1155. CrossRef
- Winner P, Gladstein J. Chronic daily headache in pediatric practice. Curr Opin Neurol 2002, 15:297–301. CrossRef
- Bigal ME, Lipton RB, Tepper SJ, et al.: Primary chronic daily headache and its subtypes in adolescents and adults. Neurology 2004, 63:843–847.
- Bigal ME, Sheftell FD, Rapoport AM, et al.: Chronic daily headache in a tertiary care population: correlation between the International Headache Society diagnostic criteria and proposed revisions of criteria for chronic daily headache. Cephalalgia 2002, 22:432–438. CrossRef
- Gladstein J, Holden EW: Chronic daily headache in children and adolescents: a 2-year prospective study. Headache 1996, 36:349–351. CrossRef
- Koenig MA, Gladstein J, McCarter RJ, et al.: Chronic daily headache in children and adolescents presenting to tertiary headache clinics. Headache 2002, 42:491–500. CrossRef
- Mack KJ: What incites new daily persistent headache in children? Pediatr Neurol 2004, 31:122–125. CrossRef
- Bigal ME, Sheftell FD, Rapoport AM, et al.: Chronic daily headache: identification of factors associated with induction and transformation. Headache 2002, 42:575–581. CrossRef
- Santoni JR, Santoni-Williams CJ: Headache and painful lymphadenopathy in extracranial or systemic infection: etiology of new daily persistent headaches. Intern Med 1993, 32:530–532. CrossRef
- Stewart WF, Scher AI, Lipton RB: Stressful life events and risk of chronic daily headache: results from the frequent headache epidemiology study. Cephalalgia 2001, 21:278–280. CrossRef
- Diaz-Mitoma F, Vanast WJ, Tyrrell DL: Increased frequency of Epstein-Barr virus excretion in patients with new daily persistent headaches. Lancet 1987, 1:411–415. CrossRef
- Rozen TD: New daily persistent headache. Curr Pain Headache Rep 2003, 7:218–223. CrossRef
- Meineri P, Torre E, Rota E, et al.: New daily persistent headache: clinical and serological characteristics in a retrospective study. Neurol Sci 2004, 25(Suppl 3):S281–S282. CrossRef
- Takase Y, Nakano M, Tatsumi C: Primary new daily persistent headache (NDPH): clinical characteristics of forty-three cases in Japan. Rinsho Shinkeigaku 2003, 43:533–538.
- Pascual J: Other primary headaches. Neurol Clin 2009, 27:557–571. CrossRef
- Lewis DW, Ashwal S, Dahl G, et al.: Practice parameter: evaluation of children and adolescents with recurrent headaches: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2002, 59:490–498. CrossRef
- Lewis DW, Dorbad D: The utility of neuroimaging in the evaluation of children with migraine or chronic daily headache who have normal neurological examinations. Headache 2000, 40:629–632. CrossRef
- Schwedt TJ, Guo Y, Rothner AD: “Benign” imaging abnormalities in children and adolescents with headache. Headache 2006, 46:387–398. CrossRef
- • Mathew NT, Jaffri SF: A double-blind comparison of onabotulinumtoxina (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic migraine: a pilot study. Headache 2009, 49:1466–1478. This study reported similar efficacy between topiramate and botulinum toxin for CM prophylaxis.
- Freitag FG, Diamond S, Diamond M, et al.: Botulinum Toxin Type A in the treatment of chronic migraine without medication overuse. Headache 2008, 48:201–209.
- Chan VW, McCabe EJ, MacGregor DL: Botox treatment for migraine and chronic daily headache in adolescents. J Neurosci Nurs 2009, 41:235–243. CrossRef
- • Spears RC: Efficacy of botulinum toxin type A in new daily persistent headache. J Headache Pain 2008, 9:405–406. This article provides a description of successful treatment of NDPH with botulinum toxin.
- Rozen T, Swidan SZ: Elevation of CSF tumor necrosis factor alpha levels in new daily persistent headache and treatment refractory chronic migraine. Headache 2007, 47:1050–1055. CrossRef
- Rozen TD: Doxycycline for treatment resistant new daily persistent headache [abstract]. Headache 2008, 48:549. CrossRef
- Wintrich S, Rothner AD: Prognosis of new daily persistent headache in children and adolescents [abstract]. Submitted for presentation at the 62nd Annual Meeting of the American Academy of Neurology. Toronto, Canada; April 10–17, 2010.
- New Daily Persistent Headache in Children and Adolescents
Current Neurology and Neuroscience Reports
Volume 10, Issue 2 , pp 127-132
- Cover Date
- Print ISSN
- Online ISSN
- Current Science Inc.
- Additional Links
- New daily persistent headache
- Chronic daily headache
- Chronic migraine
- Chronic tension-type headache
- Industry Sectors
- Author Affiliations
- 1. Department of Neurology, Center for Headache and Pain/T33, Cleveland Clinic Neurological Institute, 9500 Euclid Avenue, Cleveland, OH, 44195, USA
- 2. Center for Pediatric Neurology/S60, Cleveland Clinic Neurological Institute, 9500 Euclid Avenue, Cleveland, OH, 44195, USA